Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$58.92 - $84.67 $24,982 - $35,900
-424 Reduced 1.76%
23,628 $1.49 Million
Q2 2022

Aug 11, 2022

BUY
$79.4 - $116.36 $102,029 - $149,522
1,285 Added 5.64%
24,052 $1.96 Million
Q1 2022

May 09, 2022

BUY
$86.42 - $109.81 $70,086 - $89,055
811 Added 3.69%
22,767 $2.41 Million
Q4 2021

Feb 10, 2022

BUY
$98.56 - $119.91 $7,983 - $9,712
81 Added 0.37%
21,956 $2.34 Million
Q3 2021

Nov 12, 2021

SELL
$91.91 - $110.37 $104,593 - $125,601
-1,138 Reduced 4.95%
21,875 $2.36 Million
Q2 2021

Aug 11, 2021

BUY
$86.24 - $95.92 $1.98 Million - $2.21 Million
23,013 New
23,013 $2.2 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Opseu Pension Plan Trust Fund Portfolio

Follow Opseu Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opseu Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Opseu Pension Plan Trust Fund with notifications on news.